Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05197322
Title NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer (NEOPRISM-CRC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University College, London
Indications

rectum cancer

colon adenocarcinoma

rectum adenocarcinoma

Therapies

Pembrolizumab

Age Groups: senior | adult
Covered Countries

Additional content available in CKB BOOST